Underreporting of spinal epidural lipomatosis: A retrospective analysis of lumbosacral MRI examinations from different radiological settings.


Journal

Diagnostic and interventional imaging
ISSN: 2211-5684
Titre abrégé: Diagn Interv Imaging
Pays: France
ID NLM: 101568499

Informations de publication

Date de publication:
May 2022
Historique:
received: 15 11 2021
revised: 31 12 2021
accepted: 01 01 2022
pubmed: 20 1 2022
medline: 6 5 2022
entrez: 19 1 2022
Statut: ppublish

Résumé

The purpose of this study was to assess the rate with which radiologists reported spinal epidural lipomatosis (SEL) when interpreting lumbosacral magnetic resonance imaging (MRI) examination. A total of 450 lumbosacral MRI examinations obtained in 450 patients were included (199 men, 251 women; mean age, 56.7 ± 13.5 [SD] years; age range: 18-91 years).  Three senior radiologists assessed and classified independently SEL on MRI according to the Borré grading system (Grade 1 to Grade 3). Depiction of SEL on MRI reports (i. e., reporting rate) and association with patients' symptoms were verified. SEL was found in 75/450 patients (prevalence = 16.7%), and classified as grade-1 (mild) in 49/75 (65.3%) patients, grade-2 (moderate) in 24/75 (32%), and grade-3 (severe) in 2/75 (2.7%). SEL was diagnosed on MRI report in 6/75 (8%) patients. SEL prevalence based on MRI reports was 1.3% (6/450), significantly lower than its actual prevalence based on MRI examinations (P < 0.0001). The reporting rate was 0% in grade-1 (0/19), 10.2% in grade-2 (5/49) and 50.0% in grade-3 (1/2), and variable on the radiologist subspecialty (10.0% among musculoskeletal radiologists, 11.1% among neuroradiologists, and 3.7% among generalists). SEL was considered as the only cause of symptoms in 7/75 patients (9.3%) and a concurrent cause in 9/75 (12%). SEL reporting rate is extremely low, leading to an important underestimation of disease prevalence. SEL diagnosis and grading should be refined to improve reports quality and subsequently patient care.

Identifiants

pubmed: 35042669
pii: S2211-5684(22)00001-8
doi: 10.1016/j.diii.2022.01.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-257

Informations de copyright

Copyright © 2022. Published by Elsevier Masson SAS.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial or personal relationships that could be viewed as influencing the work reported in this paper.

Auteurs

Paolo Spinnato (P)

Diagnostic and Interventional Radiology, IRCCS Isituto Ortopedico Rizzoli, Bologna 40136, Italy. Electronic address: paolo.spinnato@ior.it.

Valerio D'Agostino (V)

Diagnostic and Interventional Radiology, IRCCS Isituto Ortopedico Rizzoli, Bologna 40136, Italy; Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples 80131, Italy.

Donato Fiorenzo (D)

Department of Neuroradiology, IRCCS Istituto delle Scienze Neurologiche, Bologna 40139, Italy.

Massimo Barakat (M)

Diagnostic and Interventional Radiology, IRCCS Isituto Ortopedico Rizzoli, Bologna 40136, Italy.

Giulio Vara (G)

Diagnostic and Interventional Radiology, IRCCS Isituto Ortopedico Rizzoli, Bologna 40136, Italy.

Federico Ponti (F)

Diagnostic and Interventional Radiology, IRCCS Isituto Ortopedico Rizzoli, Bologna 40136, Italy.

Giacomo Filonzi (G)

Department of Radiology, Ospedale Maggiore, Bologna 40133, Italy.

Amandine Crombé (A)

Department of Musculoskeletal Imaging, Pellegrin University Hospital, University of Bordeaux, Bordeaux F-33000, France.

Cecilia Tetta (C)

Diagnostic and Interventional Radiology, IRCCS Isituto Ortopedico Rizzoli, Bologna 40136, Italy.

Marco Miceli (M)

Diagnostic and Interventional Radiology, IRCCS Isituto Ortopedico Rizzoli, Bologna 40136, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH